Health charities sue FDA over extended deeming deadlines

Public health groups have brought a suit against the US Food and Drug Administration (FDA) for extending deadlines for e-cigs and cigars on its controversial deeming regulations.

They argue that these extensions keep flavours on the market, attracting young people to the products and encouraging youth uptake.

The suit was brought by a who’s who of tobacco control organisations, including the Campaign for Tobacco-Free Kids, American Cancer Society Cancer Action Network, American Heart Association, American Lung Association, Truth Initiative, and American Academy of Pediatrics.

They claim the FDA has offered “no meaningful justification for ripping a hole in the statutory framework by exempting, for more than half a decade, newly deemed products from premarket review – review FDA previously described as ‘central’ to the regulatory scheme Congress enacted for tobacco products.”

Read full article
I'm already a subscriber
Author default picture

Daniel Mollenkamp

Our Key Benefits

The global e-cigarette market is in an opaque regulatory environment that requires professionals to be on top of industry developments to make informed decisions and optimise their strategy.

ECigIntelligence provides organisations with leading market and regulatory data analysis to anticipate and understand market developments globally and the impact of regulatory changes to the business.

  • Stay informed of any legal and market change in the sector that impacts your organisation
  • Maximise resources by getting market and legal data analysis daily in one place
  • Make smart decisions by understanding how the regulatory and market landscape evolves
  • Anticipate risks in your decisions by monitoring regulatory changes that impact your organization